SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052755
Filing Date
2020-11-10
Accepted
2020-11-10 08:30:45
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fusn-10q_20200930.htm 10-Q 2352215
2 EX-10.1 fusn-ex101_279.htm EX-10.1 47782
3 EX-31.1 fusn-ex311_6.htm EX-31.1 19475
4 EX-31.2 fusn-ex312_9.htm EX-31.2 19526
5 EX-32.1 fusn-ex321_7.htm EX-32.1 9620
6 EX-32.2 fusn-ex322_8.htm EX-32.2 9617
  Complete submission text file 0001564590-20-052755.txt   8457871

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fusn-20200930.xml EX-101.INS 1723301
8 XBRL TAXONOMY EXTENSION SCHEMA fusn-20200930.xsd EX-101.SCH 63382
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fusn-20200930_cal.xml EX-101.CAL 55639
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fusn-20200930_def.xml EX-101.DEF 214099
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fusn-20200930_lab.xml EX-101.LAB 479459
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fusn-20200930_pre.xml EX-101.PRE 375526
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39344 | Film No.: 201299716
SIC: 2836 Biological Products, (No Diagnostic Substances)